• Corpus ID: 51820143

[Frontiers in Bioscience 3, d354-364, March 22, 98] 354 BIOLOGY OF VACCINIA VIRUS ACYLPROTEINS

  title={[Frontiers in Bioscience 3, d354-364, March 22, 98] 354 BIOLOGY OF VACCINIA VIRUS ACYLPROTEINS},
  author={Douglas W. Grosenbach and Dennis E. Hruby},
1. Abstract 2. Introduction 2.1 Overview of the vaccinia life cycle 2.2 Overview of protein fatty acylation 3. Identification of vaccinia acylproteins 3.1 Myristylproteins 3.2 Palmitylproteins 4. Biological significance of VV acylproteins 4.1 Myristylproteins 4.1.1 L1R 4.1.2 ATI 4.1.3 A14L 4.1.4 A16L, E7R, G9R 4.2 Palmitylproteins 4.2.1 p37 4.2.2 gp42 4.2.3 A33R 5. Perspective and future directions 5.1 Perspective 5.2 Future directions 5.2.1 Further analysis of VV myristylproteins 5.2.2 Further… 

Figures and Tables from this paper


Identification and analysis of three myristylated vaccinia virus late proteins
Time course labeling of VV-infected cells with [3H]myristic acid reveals at least three additional putative myristylproteins, with apparent molecular masses of 92, 17, and 14 kDa, providing strong evidence that the open reading frames had been correctly identified and that each protein is my Bristylated on a glycine residue adjacent to the initiating methionine.
Evidence for multiple species of vaccinia virus-encoded palmitylated proteins.
Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis
It is shown that virus growth is restored if the inducer is provided not later than 6 h postinfection and that 14-kDa envelope protein becomes posttranslationally associated to viral membranes through its interaction with the 21-k da protein.
Fatty acid acylation of vaccinia virus proteins
Vaccinia virus-infected cells with [3H]myristic acid resulted in the incorporation of label into two viral proteins with apparent molecular weights of 35,000 and 25,000 (designated M35 and M25), suggesting greater stability of these proteins or a favored interaction of the proteins containing myristate with the maturing or intracellular virion.
Biochemical analysis of the major vaccinia virus envelope antigen.
A detailed biochemical analysis of the major envelope antigen of vaccinia virus, M(r) 37,000 (p37K), showed that p37K is tightly bound to the viral envelope and resistance to proteinase K digestion indicates that it is not exposed on the surface of EEV but lines the inner side of the envelope.
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
Immunoblot analysis of purified and protease-digested intracellular mature virus (IMV) and extracellular enveloped virus (EEV) showed that the A36R proteins were present on the surface of EEV with type II membrane topology, but were absent from IMV, and delta A36G showed striking attenuation compared with WT in a murine intranasal model.
Posttranslational modification of vaccinia virus proteins.
The major features of the replication cycle of vaccinia virus (W) are outlined and the transcription of early genes is attenuated and the expression of VV late genes is initiated, which are delineated by replication of the viral DNA molecule.
Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelope.
The data obtained clearly indicate that although the L1R protein is a constituent of both the INV and EEV particles, it is exclusively found in the inner INV-specific membrane.
The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece.
It is reported that the N terminus of the 31-kDa IL-1 alpha precursor is myristoylated on specific internal lysine residues.